MHC-I expression renders catecholaminergic neurons susceptible to T-cell-mediated degeneration

Cebrián, Carolina, Zucca, Fabio A., Mauri, Pierluigi, Steinbeck, Julius A., Studer, Lorenz, Scherzer, Clemens R., Kanter, Ellen, Budhu, Sadna +5 more·2014·Nature Communications
DOI 10.1038/ncomms4633

Cited by (337)

Items 301–337 of 337

  1. Is Parkinson's Disease an Autoimmune Disease? Where the Research Is Leading
    Jamie Talan · 2017 · Neurology Today
  2. Ist Parkinson eine Alpha-Synuclein-vermittelte Autoimmmunreaktion?
    Johannes C. M. Schlachetzki · 2018 · InFo Neurologie + Psychiatrie
  3. Neurochemical Aspects of Lewy Body Dementia
    A. A. Farooqui · 2019 · Elsevier eBooks
  4. Robust Control of a Neurotropic Parasite Through MHC I Presentation by Infected Neurons
    Anna Salvioni, Marcy Belloy, Aurore Lebourg, Emilie Bassot, Vincent Cantaloube-Ferrieu, Virginie Vasseur, Sophie Blanié, Roland Liblau, Elsa Suberbielle, Ellen A. Robey et al. · 2018 · SSRN Electronic Journal
  5. Insulin resistance and Parkinson’s disease
    A. A. Farooqui · 2020 · Elsevier eBooks
  6. Public Relations Management Strategy for the Kalamazoo Institute of Arts
    Stephanie K Locke · 1997
  7. Immunoinflammatory Aspects of Parkinson’s Disease
    O. V. Belova, Tatiana I. Arefieva, Svetlana N. Moskvina · 2020 · Neuroscience and Behavioral Physiology
  8. Entstehung und Prävention altersassoziierter neurodegenerativer Erkrankungen
    Pasquale Calabrese · 2022 · Springer eBooks
  9. References
    2018 · Elsevier eBooks
  10. LRRK2-G2019S Synergizes With Ageing and Low-Grade Inflammation to Promote Gut and Peripheral Immune Cell Activation That Precede Nigrostriatal Degeneration
    Bianca Marchetti, Carmela Giachino, Cataldo Tirolo, Salvatore Caniglia, Maria Francesca Serapide, Francesca L’Episcopo, Federico Bertoli, Claudio Giuliano, Marika Mearelli, Meike Jakobi et al. · 2022 · Research Square
  11. MHC class II transactivator effects on local and systemic immune responses in an α-synuclein seeded rat model for Parkinson’s disease
    Filip Fredlund, Itzia Jiménez-Ferrer, Kathleen Grabert, Lautaro F. Belfiori-Carrasco, Kelvin C. Luk, Maria Swanberg · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  12. Novel Theranostics for Parkinson's Disease
    Benjamin William Schlichtmann · 2021
  13. References
    2024 · Elsevier eBooks
  14. Inflammatory Roads to Parkinson’s Disease
    Hymie Anisman, Shawn P. Hayley, Alexander Kusnecov · 2024 · Elsevier eBooks
  15. Introduction to mitochondrial toxicity: Form, function, and signaling
    Darci M. Fink, Ryan L. Hanson, Monica Moncada-Restrepo, Jeremy W. Chambers · 2025 · Advances in neurotoxicology
  16. Brain injury contributes to dopaminergic neurodegeneration, Lewy body pathology, and Parkinsonism preclinically with outcomes altered by T cell modulation
    Colin Kelly, Julia P. Milner, Brooke A. Lester, Samantha Brindley, L. Pastor Hernández, Sahitya Ranjan Biswas, Laura B. Murdaugh, Xiaoran Wei, Michelle Lynne Olsen, Matthew W. Buczynski et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  17. Transgenic inducible MHC I overexpression in mouse alveolar type 2 cells
    Justine Mathé, Sylvie Brochu, Marc K. Saba-El-Leil, Caroline Côté, Amrita Karia, Sébastien Harton, Claude Perreault · 2025 · Transgenic Research
  18. Neuromelanin: Bridging catecholamine metabolism and neurodegeneration in Parkinson's disease
    Marta González-Sepúlveda, Joana M. Cladera-Sastre, Miquel Vila · 2025 · Handbook of behavioral neuroscience
  19. Reevaluating the role of beta2-microglobulin: new insights on selective vulnerability in ALS pathology
    Mélanie Lebœuf, Jik Nijssen, Laura Helen Comley, Julio Cesar Aguila Benitez, Irene Mei, Silvia Gómez Alcalde, Ramón A. Muñoz de Bustillo Alfaro, Vlad Radoi, Susanne Nichterwitz, Christoph Schweingruber et al. · 2026 · Acta Neuropathologica
  20. Additional file 1 of CSF total and oligomeric α-Synuclein along with TNF-α as risk biomarkers for Parkinson’s disease: a study in LRRK2 mutation carriers
    Nour K. Majbour, Aasly, Jan O., Eldbjørg Hustad, Thomas, Mercy A., Nishant N. Vaikath, Naser Elkum, Wilma D. J. van de Berg, Tokuda, Takahiko, Brit Mollenhauer, Henk W. Berendse et al. · 2020 · Figshare
  21. Additional file 1 of Microglia/macrophages require vitamin D signaling to restrain neuroinflammation and brain injury in a murine ischemic stroke model
    Pan Cui, Wanting Lu, Wang, Junjie, Wang, Fei, Xiyue Zhang, Xiaodan Hou, Fang Xu, Liang, Yan, Guoliang Chai, Hao, Junwei · 2023 · Figshare
  22. Genome-wide identification and characterization of QTLs for transcriptional noise in human midbrain cells
    Naoki Hirose, Shota Mizuno, Yuki Niwa, Tomonori Hara, Hirona Yamamoto, Emiko Koyama, Junko Ueda, Takashi Tsuboi, Atsushi Takata · 2026 · Cell Reports
  23. Contrôle de l'activation microgliale par les lymphocytes T dans un modèle murin de neurodégénérescence induite par la 6-OHDA
    Josselin Uhlrich · 2014 · theses.fr (ABES)
  24. La neuroimmunité dans la sclérose latérale amyotrophique
    Emmanuelle Coque · 2017
  25. Understanding the role of perivascular macrophages in Parkinson's disease pathophysiology
    Jaime R. Fuentealba · 2017
  26. Major histocompatibility complex class I presentation and CD8 T cell responses during cerebral toxoplasmosis
    Anna Salvioni · 2018
  27. Microglia crosstalk with T cells in neurodegenerative diseases: pathogenesis and treatment targets
    G Chen, Cong Zhao, Chun Wang, G Chen, Jingming Shi, Huihui Chen · 2026 · International Immunopharmacology
  28. Hippocampal neuronal hypoexcitability contributes to PTSD-like phenotypes in the experimental autoimmune encephalomyelitis model
    Xinghua Zhong, Han Zhang, Jieying Xie, Yang Gao, Honghao Wang, Yujie Peng, Feng Yi, Jinyu Chen · 2026 · Frontiers in Psychiatry
  29. Neuronal expression of β2M and MHC I are essential for peripheral surveillance and targeting of neuron-restricted antigens
    Benjamin D. S. Clarkson, Melanie E Schille, Ivy J. Z. Garland, Maria S. Westphal, Charles L. Howe · 2026 · Frontiers in Neurology
  30. Mechanisms of Idiopathic Neurodegeneration in Substantia Nigra Neurons: Biochemical, Physiological, and Immuno-Humoral Perspectives
    Vladimir N. Nikolenko, N. A. Rizaeva, Marine V. Oganesyan, Maria Zubkova, Maria Sergeevna Golyshkina, Maria A. Orluk, Yane C. Pelicer, Ruslan Sabekia, Artyom Morozow, Lucas Alves Sarmento Pires et al. · 2026 · Current Behavioral Neuroscience Reports
  31. Association between Alzheimer’s disease and MHC-I antigen processing and presentation pathway: a narrative review
    Ce Wang, Q I Yun, Zuoming Zhang, Hongyun Zhao, Fangzhao Lin, Haijun Cao · 2026 · Frontiers in Immunology
  32. Age-dependent brain pigmentation drives early neuroinflammatory molecular signatures linked to neurodegeneration
    Núria Peñuelas, Helena Xicoy, Marina Lorente Picón, Alba Nicolau, Annabelle Parent, Marta González-Sepúlveda, Ariadna Laguna, Miquel Vila · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
  33. Parkinson’s Disease: Current Knowledge and Future Focus
    Caroline B. Pantazis, Todd Sherer, Ekemini A. U. Riley · 2026 · Springer eBooks
  34. Neuroinflammation and metabolic reprogramming in Parkinson’s disease
    Yixin Fu, Jianghao Yu, Lu Xu, Tingting Zhou, Qingshan Deng · 2026 · Frontiers in Immunology
  35. Decoding subtype development and function in human pluripotent stem cell-derived midbrain dopaminergic neurons
    Donghe Yang, Sejoon Choi, Jinghua Piao, Alessandro Evangelisti, Zhe Yang, Vittoria Dickinson Bocchi, Shkurte Ademi Donohue, Nidia Claros, Johannes Jungverdorben, Mega Sidharta et al. · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
  36. Role of T cells in Parkinson’s disease
    Denise Koops, Rebecca Lehmann, Frans Bianchi, Geert van den Bogaart · 2026 · BMJ Immunology
  37. CD8+ t cell-mediated regulation of synaptic integrity in Alzheimer’s disease
    Hua Fu, Jing Yang, Miao Zhang · 2026 · Frontiers in Immunology